Skip to main content
  • Faculty & Staff in the News through December

    The clickable links below navigate directly to outside media articles which featured Department of Medicine faculty and staff throughout the month of December 2025. Research led by Heather Henderson, DVM, MPH, PhD, and David van Duin, MD, PhD, showed neighborhood deprivation drives higher antimicrobial resistance and mortality in Enterobacterales infections. UNC IGHID has been hi … Read more

  • Faculty & Staff in the News through November

    The clickable links below navigate directly to outside media articles which featured Department of Medicine faculty and staff throughout the month of November 2025. Chad Pecot, MD: “If you’re, trying to make a difference in cancer, you can’t go slow.” Read the article here. Scott Commins, MD, PhD, was featured in an NBC article about the first death caused by alpha-gal syndrome. … Read more

  • Faculty & Staff in the News through October

    The clickable links below navigate directly to outside media articles which featured Department of Medicine faculty and staff throughout the month of September 2025. Samuel Short, MD,helped develop a calculatorfor physicians to better predict stroke risk in Afib patients David Weber, MD, MPH,commented on the whooping cough spike in NC. Janet Rubin, MD, advocated for resistance tr … Read more

  • Faculty & Staff in the News through September

    The clickable links below navigate directly to outside media articles which featured Department of Medicine faculty and staff throughout the month of September 2025. Millie Long, MD, MPH, and Edward Barnes, MD, MPH, played key roles in developing the first international guidelines for managing inflammatory bowel disease during pregnancy. Christine Vigeland, MD, received at R03 fr … Read more

  • Evan Dellon Leads Phase 3 Trial on Cendakimab for Eosinophilic Esophagitis

    Evan Dellon, MD, MPH, a Professor in the Division of Gastroenterology and Hepatology at UNC and the Director of the Center for Esophageal Diseases and Swallowing, led a Phase 3 Trial on using Cendakimab for Eosinophilic Esophagitis (EoE). His study was published in NEJM Evidence with positive findings. Cendakimab is a high-affinity monoclonal antibody that blocks IL-13 by prevent … Read more

  • Robert Sandler, MD, MPH/Photo courtesy of Brian Strickland

    Center for Gastrointestinal Biology and Disease Receives 40th Consecutive Year of NIH Funding

    Pictured are Dr. Robert Sandler and Julianne O’Daniel. Robert Sandler, MD, MPH, Professor of Medicine at the University of North Carolina at Chapel Hill and Director of the Center for Gastrointestinal Biology and Disease (CGIBD), has announced the renewal of the Center’s P30 Center grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This renew … Read more

  • Millie Long and Edward Barnes

    Long, Barnes Contribute to First Global Guidelines for Pregnancy and IBD

    Millie Long, MD, MPH, Chief of the Division of Gastroenterology and Hepatology at UNC-Chapel Hill, and Edward Barnes, MD, MPH, Co-Director of the UNC Multidisciplinary IBD Center, played key roles in developing the first international guidelines for managing inflammatory bowel disease (IBD) during pregnancy, along with Uma Mahadevan, MD, PI and director of the Colitis and Crohn’s … Read more

  • Faculty & Staff in the News through August

    The clickable links below navigate directly to outside media articles which featured Department of Medicine faculty and staff throughout the month of August 2025. Klara Klein, MD, PhD, will serve as PI for the UNC site investigating cadisegliatin as an adjunctive treatment to insulin in adults with type 1 diabetes. The Division of Hospital Medicine met many milestones during Fisc … Read more

  • Shehzad Z. Sheikh, MD, PhD

    Shehzad Sheikh Identifies CADM1 as a Key Driver of Gut Inflammation in IBD Patients

    Shehzad Z. Sheikh, MD, PhD A groundbreaking study co-led by Shehzad Z. Sheikh, MD, PhD, professor of medicine in the UNC Division of Gastroenterology and Hepatology, and Matthew N. Poy, PhD, associate professor of medicine with Johns Hopkins University, reveals Cell Adhesion Molecule 1 (CADM1), a surface protein involved in cell-cell adhesion, is significantly elevated in the int … Read more

  • Evan S. Dellon, MD, MPH

    PROMOTER Study Aims to Advance Translational Research in Esophageal Diseases

    Researchers from the University of North Carolina and North Carolina State University aim to use a pig-based model to study esophageal diseases, a field where scientific understanding remains limited. Researchers use large animal models to help with therapy development, testing and translation. However, fully defined models of digestive diseases are still scarce. Within this fiel … Read more

  • Faculty & Staff in the News Throughout June

    The clickable links below navigate directly to outside media articles which featured Department of Medicine faculty and staff throughout the month of June 2025. David Wohl, MD, had a video interview on injectable PrEP. Sarah McGill, MD, spoke about alpha-gal syndromes’ effect on the digestive system. Onyinye I. Iweala, MD, PhD, did a Q&A on managing care for patients with ins … Read more

  • Dr. Barlowe and Dr.McGill

    Fellow and Faculty Conduct Comparative C. Diff Study

    Dr. Barlowe and Dr.McGill Sarah McGill, MD, MSc a gastroenterologist and endoscopist, and Trevor Barlowe, MD, a gastroenterology fellow, have found that a newly-approved treatment for C. diff. infection, called fecal microbiota spores, may be associated with a particularly harmful rebound of infection, compared to traditional therapy. Their results were published in Clinical Gast … Read more